Absolute ethanol sclerotherapy for lymphangioma circumscriptum

Not Applicable

• Conditions: lymphangioma circumsriptum; lymphangioma, lympnatic malformation, skin

• Registration Number: JPRN-jRCTs031180276
• Lead Sponsor: Fujino Akihiro

Brief Summary

The purpose of this study was to evaluate the efficacy and safety of localized injection therapy with anhydrous ethanol for lymphangioma circumscriptum, which is known as a refractory lesion. The efficacy of the treatment was demonstrated in terms of the percentage of improvement in two parameters: erythema and bulging. No adverse events requiring treatment were observed and there were no safety issues.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-14
• Study Completion: 2020-02-22
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

Any lymphangioma circumscriptum patients requiring treatment who had given us an informed consent to participate in this clinical study

Exclusion Criteria

hypersensitivity to alcohol

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of the lesion

Secondary Outcome Measures

Name	Time	Method
Improvement of the symptom